Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-01 4:39 pm Purchase | 13G | Tectonic Therapeutic Inc. TECX | EcoR1 Capital LLC | 849,143 5.8% | 849,143 (New Position) | View |
| 2024-05-31 5:25 pm Purchase | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital LLC | 5,717,324 5.9% | 1,122,300 (+24.42%) | View |
| 2024-05-03 5:02 pm Purchase | 13G | Morphic Holding Inc. MORF | EcoR1 Capital LLC | 3,014,752 6% | 2,803,490 (+1327.02%) | View |
| 2024-04-08 2:46 pm Purchase | 13G | LENZ Therapeutics Inc. LENZ | EcoR1 Capital LLC | 1,219,774 4.8% | 1,219,774 (New Position) | View |
| 2024-03-26 11:59 am Purchase | 13G | Adaptimmune Therapeutics PLC ADAP | EcoR1 Capital LLC | 164,424,420 10.7% | 51,000,000 (+44.96%) | View |
| 2024-03-11 3:34 pm Purchase | 13G | Crinetics Pharmaceuticals Inc. CRNX | EcoR1 Capital LLC | 4,155,375 5.3% | 4,155,375 (New Position) | View |
| 2024-02-22 7:01 pm Unchanged | 13D | ZYMEWORKS INC ZYME | EcoR1 Capital LLC | 14,132,291 19.99% | 0 (Unchanged) | View |
| 2024-02-16 12:54 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | EcoR1 Capital LLC | 1,944,672 5.4% | 1,944,672 (New Position) | View |
| 2024-02-15 11:38 am Unchanged | 13G | Morphic Holding Inc. MORF | EcoR1 Capital LLC | 211,262 0.4% | 0 (Unchanged) | View |
| 2024-02-15 11:35 am Unchanged | 13G | Atea Pharmaceuticals Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 0 (Unchanged) | View |
| 2024-02-15 09:15 am Unchanged | 13G | Atea Pharmaceuticals Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 0 (Unchanged) | View |
| 2024-02-14 8:02 pm Purchase | 13G | Atea Pharmaceuticals Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 811,000 (+13.11%) | View |
| 2024-02-14 7:54 pm Sale | 13G | Morphic Holding Inc. MORF | EcoR1 Capital LLC | 211,262 0.4% | -3,740,304 (-94.65%) | View |
| 2024-02-14 6:59 pm Purchase | 13G | ZYMEWORKS INC ZYME | EcoR1 Capital LLC | 14,132,291 19.99% | 694,818 (+5.17%) | View |
| 2024-02-14 6:54 pm Unchanged | 13G | Xencor Inc XNCR | EcoR1 Capital LLC | 5,282,516 8.7% | 0 (Unchanged) | View |
| 2024-02-14 6:49 pm Sale | 13G | Tempest Therapeutics Inc. TPST | EcoR1 Capital LLC | 0 0% | -1,052,810 (Position Closed) | View |
| 2024-02-14 6:45 pm Purchase | 13G | Third Harmonic Bio Inc. THRD | EcoR1 Capital LLC | 3,182,444 7.9% | 200,000 (+6.71%) | View |
| 2024-02-14 6:41 pm Sale | 13G | SpringWorks Therapeutics Inc. SWTX | EcoR1 Capital LLC | 0 0% | -3,460,208 (Position Closed) | View |
| 2024-02-14 6:30 pm Sale | 13G | Revolution Medicines Inc. RVMD | EcoR1 Capital LLC | 132,579 0.1% | -7,066,121 (-98.16%) | View |
| 2024-02-14 6:19 pm Purchase | 13G | Oric Pharmaceuticals Inc. ORIC | EcoR1 Capital LLC | 6,275,210 8.9% | 2,857,142 (+83.59%) | View |